Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
Conditions
Breast Cancer · HER2-negative Breast Cancer · Hormone Receptor Positive Tumor · Premenopausal Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
ICO Badalona, Badalona, Barcelona, Spain
Contact: Principal Investigator (Eudald Felip)ICO Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain
Contact: Principal Investigator (Verónica Obadia)Hospital Universitari Arnau de Vilanova de Lleida, Vilanova, Lleida, Spain
Contact: Principal Investigator (Serafín Morales)Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
Contact: Principal Investigator (Pilar Sánchez)Hospital Universitario de Badajoz, Badajoz, Spain
Contact: Principal Investigator (Alba González-Haba)Hospital Universitari Vall d'Hebron, Barcelona, Spain
Contact: Study coordinator (Meritxell Bellet)Contact: Principal Investigator (Meritxell Bellet)Hospital Clinic de Barcelona, Barcelona, Spain
Contact: Study coordinator (Maria Vidal, MD)Complejo Hospitalario San Pedro de Alcántara, Cáceres, Spain
Contact: Study coordinator (Santiago González, MD)HM Sanchinarro (CIOCC), Madrid, Spain
Contact: Principal Investigator (Patricia Cortés)Hospital Universitario 12 de Octubre, Madrid, Spain
Contact: Study coordinator (Pablo Tolosa, MD)Hospital Universitario Central de Asturias, Oviedo, Spain
Contact: Study coordinator (Paula García Tejido)Hospital Universitari Son Espases, Palma de Mallorca, Spain
Contact: Principal Investigator (Antonia Perelló)Complejo Hospitalario de Navarra, Pamplona, Spain
Contact: Principal Investigator (Susana De la Cruz)Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Spain
Contact: Study coordinator (Vanesa Ortega)Hospital Clínico de Valencia, Valencia, Spain
Contact: Study coordinator (Cristina Hernando, MD)